Molecular Status 36 Months after TKI Discontinuation in CML is Highly Predictive for Subsequent Loss of MMR—final Report from AFTER-SKI
Leukemia(2021)
关键词
Chronic myeloid leukaemia,Phase II trials,Medicine/Public Health,general,Internal Medicine,Intensive / Critical Care Medicine,Cancer Research,Oncology,Hematology
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要